Skip to main content

NSRX · Nasus Pharma Ltd · Holdings

Track NSRX — free
$3.40 +0.05 (+1.64%) At close · Sep 11
Market Cap
$39.88M
Shares
11.71M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 10
Total Value: $7,526,437
Total Shares: 2,150,411

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 10 13F filers · Δ vs Mar 31, 2026
Top Holder
41.8%
Sep 2025 → Jun 2026 · range 41.3% – 84.1%
+0.5 pts
Top 5
97.6%
Sep 2025 → Jun 2026 · range 95.9% – 100.0%
+1.7 pts
Top 10
100.0%
Sep 2025 → Jun 2026 · range 100.0% – 100.0%
0.0 pts
HHI
2,904
Sep 2025 → Jun 2026 · range 2,811 – 7,327
Highly concentrated+94

Quarterly Activity

vs Mar 31, 2026
New
4
Increased
1
Decreased
1
Sold Out
3
Unchanged
4
Holder count: +1
Institutional value: +55.9%
Shares held: -1.1%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 10 of 10
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2029039 CUSIP M7071P109 13F (30d) 6 filings 6 filers Visit website Investor relations